VAXICAN is a startup based in Poland.
VAXICAN develops next-generation immunotherapeutics focusing on prophylactic cancer vaccines using a virus-like particle platform to stimulate immune responses, and provides next-generation genome sequencing services under Vaxican Genomics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.